SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-24-032407
Filing Date
2024-03-08
Accepted
2024-03-08 16:18:34
Documents
20
Period of Report
2024-04-26

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm242772d4_pre14a.htm   iXBRL PRE 14A 945132
6 GRAPHIC bc_netincome-4c.jpg GRAPHIC 85838
7 GRAPHIC bc_totalshare-4c.jpg GRAPHIC 69481
8 GRAPHIC ic_arrow-bw.jpg GRAPHIC 1737
9 GRAPHIC lg_veronapharma-4c.jpg GRAPHIC 12607
  Complete submission text file 0001104659-24-032407.txt   1915239

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrna-20231231.xsd EX-101.SCH 8157
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vrna-20231231_def.xml EX-101.DEF 5580
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20231231_lab.xml EX-101.LAB 27390
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20231231_pre.xml EX-101.PRE 4740
21 EXTRACTED XBRL INSTANCE DOCUMENT tm242772d4_pre14a_htm.xml XML 63102
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38067 | Film No.: 24734620
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)